Sign in:
 Email
 Password  save:
  
 Company Reports 
 
 
Membership is free, please Sign Up.
  
My Recent Searches
  Help
  
   
 
 
Get Insiders for : 
Coherus Biosciences, Inc. (CHRS)  
$2.27 0.10 (4.61%) as of 4:30 Fri 5/3


Download
   
Exchange: N/A
Security Type: N/A
Shares Out: 82,625,000
Market Cap: 187.56(M)
Last Volume: 0 Avg Vol: 0
52 Week Range: $1.59 - $8.14
Level I Sector: N/A
Level II Sector: N/A
Level III Sector: N/A

Member Indexes:
   

Rankings:
     
Insider 3 Months    :   -
Insider 6 Months    :   -
Insider 3/6 Months :   -
Guru Rank Number :  -
Guru Rank Value     :  -
Guru Occurances    :  -

 

            6 Months   1 Year   2 Year  
 
Company Profile   Coherus BioSciences is a commercial-stage biopharmaceutical company focused on the research, development and commercialization of immunotherapies to treat cancer. Co. in-licensed its lead immuno-oncology product candidate, toripalimab (CHS-007), an anti-PD-1 antibody, from Shanghai Junshi Biosciences Co., Ltd. Toripalimab is being evaluated in late-stage clinical trials for the treatment of a range of tumor types. Co.'s commercial portfolio includes two U.S. Food and Drug Administration-approved biologics, including UDENYCA® (pegfilgrastim-cbqv), a biosimilar to Neulasta®, a granulocyte-colony stimulating factor and YUSIMRY™ (adalimumab-aqvh), its Humira® (adalimumab) biosimilar product.

 
 
Summary  (Direct Transactions Only) 3 Months 6 Months 12 Months 24 Months
Total Shares Bought 0 0 0 0
Total Buy Value $0 $0 $0 $0
Total People Bought 0 0 0 0
Total Buy Transactions 0 0 0 0
Total Shares Sold 0 223,100 223,100 223,100
Total Sell Value $0 $449,770 $449,770 $449,770
Total People Sold 0 1 1 1
Total Sell Transactions 0 1 1 1
End Date 2024-02-04 2023-11-03 2023-05-05 2022-05-05

   
Records found: 312
  Page 9 of 13  
Filer's Name Relation Title Off-Dir-10% Tran. Date Form Action Price Mkt Value D/I Shares Holdings
Rank

  
3m +/-  
Form
   Wahlstrom Mats Director   –       •      –    2017-02-22 4 D $0.00 $0 I/I (200,000) 378,528     -
   Viret Jean-Frederic Chief Financial Officer   •       –      –    2017-01-25 4 AS $27.00 $105,300 D/D (3,900) 2,992     -
   Viret Jean-Frederic Chief Financial Officer   •       –      –    2017-01-25 4 OE $13.50 $52,650 D/D 3,900 6,892     -
   Herman Alan C. Chief Scientific Officer   •       –      –    2017-01-03 4 AS $27.90 $316,722 D/D (11,333) 124,451     -
   Viret Jean-Frederic Chief Financial Officer   •       –      –    2016-12-19 4 OE $13.50 $9,005 D/D 667 2,992     -
   Viret Jean-Frederic Chief Financial Officer   •       –      –    2016-12-16 4 AS $28.30 $110,365 D/D (3,900) 2,325     -
   Viret Jean-Frederic Chief Financial Officer   •       –      –    2016-12-16 4 OE $13.50 $52,650 D/D 3,900 6,225     -
   Wahlstrom Mats Director   –       •      –    2016-12-08 4 S $27.52 $1,271,347 I/I (46,190) 0     -
   Wahlstrom Mats Director   –       •      –    2016-12-07 4 S $27.50 $203,330 I/I (7,393) 46,190     -
   Herman Alan C. Chief Scientific Officer   •       –      –    2016-12-01 4 AS $27.01 $310,523 D/D (11,333) 135,784     -
   Viret Jean-Frederic Chief Financial Officer   •       –      –    2016-11-18 4 AS $28.19 $109,955 D/D (3,900) 2,325     -
   Viret Jean-Frederic Chief Financial Officer   •       –      –    2016-11-18 4 OE $13.50 $52,650 D/D 3,900 6,225     -
   Herman Alan C. Chief Scientific Officer   •       –      –    2016-11-01 4 AS $27.53 $312,042 D/D (11,333) 147,117     -
   Viret Jean-Frederic Chief Financial Officer   •       –      –    2016-10-21 4 AS $30.62 $119,403 D/D (3,900) 2,325     -
   Viret Jean-Frederic Chief Financial Officer   •       –      –    2016-10-21 4 OE $13.50 $52,650 D/D 3,900 6,225     -
   Herman Alan C. Chief Scientific Officer   •       –      –    2016-10-03 4 AS $25.47 $291,201 D/D (11,333) 158,450     -
   Viret Jean-Frederic Chief Financial Officer   •       –      –    2016-09-26 4 AS $29.88 $116,550 D/D (3,900) 2,325     -
   Viret Jean-Frederic Chief Financial Officer   •       –      –    2016-09-26 4 OE $13.50 $52,650 D/D 3,900 6,225     -
   Lanfear Dennis M President and CEO   •       •      –    2016-09-21 4 AS $31.75 $1,588 I/I (50) 1,337,566     -
   Lanfear Dennis M President and CEO   •       •      –    2016-09-20 4 AS $31.75 $127,322 I/I (4,010) 1,337,616     -
   Lanfear Dennis M President and CEO   •       •      –    2016-09-16 4 AS $31.79 $92,199 I/I (2,900) 1,341,626     -
   Herman Alan C. Chief Scientific Officer   •       –      –    2016-09-01 4 AS $29.99 $509,715 D/D (16,999) 169,783     -
   Watler Peter K. Chief Technical Officer   •       –      –    2016-08-08 4 AS $30.00 $468,649 I/I (15,621) 0     -
   Watler Peter K. Chief Technical Officer   •       –      –    2016-08-08 4 OE $2.50 $39,060 I/I 15,621 15,621     -
   Watler Peter K. Chief Technical Officer   •       –      –    2016-08-08 4 AS $30.00 $1,200,016 D/D (40,000) 0     -
  312 Records found
  1  2  3  4  5  6  7  8  9  Next   
  Page 9 of 13
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
  OE - Options Exercised A - Acquired
  IO - Initital Ownership D - Disposed
 
 
    Copyright © 2024 j3sg.com | Disclaimer & Terms of use          Products & Service  About Us  Contact Us